Revoking pharma patents
Cancellation and opposition actions are an important weapon in the armoury of generic companies. Soledad Betanzos-Lara of Goodrich Riquelme y Asociados provides an insight to proceedings in Mexico
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: